The role of the prolactin receptor pathway in the pathogenesis of glioblastoma: What do we know so far?

Taylor and Francis Group, Expert Opinion on Therapeutic Targets, 11(24), p. 1121-1133, 2020

Journal article published in 2020 by Antonela S. Asad

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by